Rift Valley Fever Virus MP-12 Vaccine Is Fully Attenuated by a Combination of Partial Attenuations in the S, M, and L Segments.
about
Has Rift Valley fever virus evolved with increasing severity in human populations in East Africa?Temperature-sensitive mutations for live-attenuated Rift Valley fever vaccines: implications from other RNA virusesMP-12 virus containing the clone 13 deletion in the NSs gene prevents lethal disease when administered after Rift Valley fever virus infection in hamstersThe L, M, and S Segments of Rift Valley Fever Virus MP-12 Vaccine Independently Contribute to a Temperature-Sensitive Phenotype.Mutational Analysis of the Rift Valley Fever Virus Glycoprotein Precursor Proteins for Gn Protein Expression.Short Interfering RNA Inhibits Rift Valley Fever Virus Replication and Degradation of Protein Kinase R in Human Cells.Attenuation of pathogenic Rift Valley fever virus strain through the chimeric S-segment encoding sandfly fever phlebovirus NSs or a dominant-negative PKR.The two faces of Rift Valley fever virus virulence factor NSs: The development of a vaccine and the elucidation of pathogenesis.Rift Valley fever vaccines: an overview of the safety and efficacy of the live-attenuated MP-12 vaccine candidate.Risk analysis of inter-species reassortment through a Rift Valley fever phlebovirus MP-12 vaccine strain.Attenuation and protective efficacy of Rift Valley fever phlebovirus rMP12-GM50 strain.Genetic stability of Rift Valley fever virus MP-12 vaccine during serial passages in culture cells.
P2860
Q26314582-EE96D04A-CA56-4C25-874A-E21E49321D90Q26796199-13EE5F7B-CDAA-47AF-B15E-3EF0418E0CFAQ35792819-C6B31887-F770-4422-9BF2-4A45ADD9AEAAQ36694012-E23D6479-10E2-464A-87F3-011BD899F9A3Q37049951-CFA16435-D805-4CAD-BBEE-341F9A859809Q37433779-E146ED50-045E-4366-A136-4AF88ED46FCEQ37509225-07EC077B-AE15-42E2-A746-1A492ACDE716Q37509231-F88090B7-7FCC-41BE-B5ED-81DE26128904Q39251803-01AA4275-A326-4083-9097-76C75D5794DFQ41677275-09161408-0746-4C80-829B-07011FE18869Q43167996-FF3332F8-A6F0-4923-A945-7738090DFD5AQ44170263-5A0EFABA-A9E2-4A8D-8B1D-93600712B465
P2860
Rift Valley Fever Virus MP-12 Vaccine Is Fully Attenuated by a Combination of Partial Attenuations in the S, M, and L Segments.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Rift Valley Fever Virus MP-12 ...... s in the S, M, and L Segments.
@ast
Rift Valley Fever Virus MP-12 ...... s in the S, M, and L Segments.
@en
Rift Valley Fever Virus MP-12 ...... s in the S, M, and L Segments.
@nl
type
label
Rift Valley Fever Virus MP-12 ...... s in the S, M, and L Segments.
@ast
Rift Valley Fever Virus MP-12 ...... s in the S, M, and L Segments.
@en
Rift Valley Fever Virus MP-12 ...... s in the S, M, and L Segments.
@nl
prefLabel
Rift Valley Fever Virus MP-12 ...... s in the S, M, and L Segments.
@ast
Rift Valley Fever Virus MP-12 ...... s in the S, M, and L Segments.
@en
Rift Valley Fever Virus MP-12 ...... s in the S, M, and L Segments.
@nl
P2093
P2860
P356
P1433
P1476
Rift Valley Fever Virus MP-12 ...... ns in the S, M, and L Segments
@en
P2093
Alexander N Freiberg
Jennifer K Smith
Lihong Zhang
Nandadeva Lokugamage
Olga A L Slack
Terence E Hill
Terry L Juelich
P2860
P304
P356
10.1128/JVI.00135-15
P407
P577
2015-05-06T00:00:00Z